AUTOMERA US INC.

Profile

Company Names

AUTOMERA US INC.

Addresses

2815 EASTLAKE AVE E #300, SEATTLE, WA 98102

Phone Numbers

206-957-7300

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2023

State Incorporated:

DELAWARE

Total Amount Raised:

$12,199,998.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2023-09-05 
$12,199,998.00 
$20,649,999.00 
$8,450,001.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SEAN 
 
CASSIDY 
DIRECTOR
ARVINAS HOLDING COMPANY, LLC   |  ARVINAS, INC.   |  MEGAPORT LTD   |  LUCEM HEALTH, INC.   |  ABBRATECH HOLDINGS LLC   |  AUTOMERA US INC.   |  QUARRY DAC, INC   |  DURACRIN, LLC   |  QUARRY HEME, INC
YU-CHIEH ALICE 
 
CHEN 
DIRECTOR
AUTOMERA US INC.
WEN QI 
 
HO 
DIRECTOR
AUTOMERA US INC.
IAN 
 
HOWES 
EXECUTIVE OFFICER, PROMOTER
AKEBIA THERAPEUTICS, INC.   |  INFUSION MEDICAL, INC.   |  MAGNOLIA NEUROSCIENCES CORP   |  RODEO THERAPEUTICS CORP   |  KAYOTHERA, INC.   |  AUTOMERA US INC.
MITCHELL 
 
HYMOWITZ 
EXECUTIVE OFFICER
LIGHT SCIENCES ONCOLOGY INC   |  GUIDE-LINK, INC.   |  RIGHTWARE, INC.   |  APPATTACH INC.   |  CAMP NATIVE, INC.   |  THEO CHOCOLATE INC   |  AUTOMERA US INC.
THONG 
 
LE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
XORI CORP   |  MIRINA CORP   |  ACYLIN THERAPEUTICS, INC.   |  ONCOFACTOR CORP   |  GROOVE BIOPHARMA CORP   |  QAZZOW, INC.   |  LODO THERAPEUTICS CORP   |  PETRA PHARMA CORP   |  APOGEN BIOTECHNOLOGIES, INC.   |  RODEO THERAPEUTICS CORP   |  PRONIRAS CORP   |  MAGNOLIA NEUROSCIENCES CORP   |  KAYOTHERA, INC.   |  AUTOMERA US INC.
KENDALL 
 
MOHLER 
EXECUTIVE OFFICER
TRUBION PHARMACEUTICALS, INC   |  MAGNOLIA NEUROSCIENCES CORP   |  RODEO THERAPEUTICS CORP   |  KAYOTHERA, INC.   |  AUTOMERA US INC.
SUZANNE 
 
RETTENMIER 
EXECUTIVE OFFICER
RODEO THERAPEUTICS CORP   |  KAYOTHERA, INC.   |  AUTOMERA US INC.
BENJAMIN ZIAN-LOONG 
 
WANG 
DIRECTOR
AUTOMERA US INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-10-17
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-09-05 
2023-09-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-09-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#